The challenge of chronic lung disease in HIV-infected children and adolescents

Journal of the International AIDS Society

Volumn 16, Issue , 2013, Pages

  Weber, Heinrich C ^a   Gie, Robert P ^b   Cotton, Mark F ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Adolescent; Bronchiectasis; Children; Chronic lung disease; HIV; LIP; Tuberculosis (TB)

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT DISEASE; AFRICA SOUTH OF THE SAHARA; ANTIVIRAL THERAPY; ASPIRATION PNEUMONIA; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CHILDHOOD DISEASE; CHRONIC LUNG DISEASE; ECHOCARDIOGRAPHY; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG FUNCTION TEST; LYMPHOID INTERSTITIAL PNEUMONITIS; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOGRAPHY; RECURRENT ASPIRATION; REVIEW; STAPHYLOCOCCUS AUREUS; TREATMENT RESPONSE; TUBERCULOSIS; ADOLESCENT; CHILD; CHRONIC DISEASE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIP; LUNG DISEASE; PATHOLOGY; TUBERCULOSIS (TB);

ADOLESCENT; BRONCHIECTASIS; CHILDREN; CHRONIC LUNG DISEASE; HIV; LIP; TUBERCULOSIS (TB);

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; CHILD; CHRONIC DISEASE; HIV INFECTIONS; HUMANS; LUNG DISEASES;

EID: 84887281119     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.16.1.18633     Document Type: Review

References (40)

1. Ferrand RA, Luethy R, Bwakura F, Mujuru H, Miller RF, Corbett EL. HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe. Clin Infect Dis. 2007;44(6):874-8.
2. Ferrand RA, Corbett EL, Wood R, Hargrove J, Ndhlovu CE, Cowan FM, et al. AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS. 2009;23(15):2039-46.
3. UNAIDS: UNAIDS report on the global AIDS epIdemIc: 2012. In. Edited by (UNAIDS) JUNPoHA; 2012.
4. Zar HJ. Chronic lung disease in human immunodeficiency virus (HIV) infected children. Pediatr Pulmonol. 2008;43(1):1-10.
5. Ferrand RA, Bandason T, Musvaire P, Larke N, Nathoo K, Mujuru H, et al. Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey. PLoS Med. 2010;7(2):e1000178.
6. Ferrand RA, Desai SR, Hopkins C, Elston CM, Copley SJ, Nathoo K, et al. Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis. 2012;55(1):145-52.
7. Rylance J, Mwalukomo T, Rylance S, Matchere P, Thindwa D, Webb E, et al. Lung Function and Bronchodilator Response in Perinatally HIV-infected Adolescents: Malawi. In: Programs and abstracts of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012); 2012 March 5-8; Seattle, Washington, USA.
8. Amorosa JK, Miller RW, Laraya-Cuasay L, Gaur S, Marone R, L.D. F, Nosher JL. Bronchiectasis in children with lymphocytic interstitial pneumonia and acquired immunodeficiency syndrome. Pediatr Radiol. 1992;22:603-7.
9. Berman DM, Mafut D, Djokic B, Scott G, Mitchell C. Risk factors for the development of bronchiectasis in HIV-infected children. Pediatr Pulmonol. 2007;42(10):871-5.
10. Jeena PM, Coovadia HM, Thula SA, Blythe D, Buckels NJ, Chetty R. Persistent and chronic lung disease in HIV-1 infected and uninfected African children. AIDS. 1998;12:1185-93.
11. Kiwanuka J, Graham SM, Coulter JB, Gondwe JS, Chilewani N, Carty H, et al. Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann Trop Paediatr. 2001;21(1):5-14.
12. Masekela R, Anderson R, Moodley T, Kitchin OP, Risenga SM, Becker PJ, et al. HIV-related bronchiectasis in children: an emerging spectre in high tuberculosis burden areas. Int J Tuberc Lung Dis. 2012;16(1):114-9.
13. Norton KI, Kattan M, Rao JS, Cleveland R, Trautwein L, Mellins RB, et al. Chronic radiographic lung changes in children with vertically transmitted HIV-1 infection. AJR Am J Roentgenol. 2001;176(6):1553-8.
14. Sheikh S, Madiraju K, Steiner P, Rao M. Bronchiectasis in pediatric AIDS. Chest. 1997;112(5):1202-7.
15. Andiman WA, Eastman R, Martin K, Katz BZ, Rubinstein A, Pitt J, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet. 1985;2(8469-70):1390-3.
16. Dufour V, Wislez M, Bergot E, Mayaud C, Cadranel J. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003;36(10):e127-30.
17. King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2009;4:411-9.
18. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55(1):32-8.
19. Ehrlich RI, Adams S, Baatjies R, Jeebhay MF. Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis. 2011;15(7):886-91.
20. Dickey LB. Primary pulmonary tuberculosis as a cause of bronchiectasis in children. Dis Chest. 1952;21(3):260-7.
21. Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children. Curr Opin Pediatr. 2008;20(3):272-8.
22. Fischer GB, Sarria EE, Mattiello R, Mocelin HT, Castro-Rodriguez JA. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev. 2010;11(4):233-9.
23. Pitcher RD, Goddard E, Hendricks M, Lawrenson J. Chest radiographic pulmonary changes reflecting extrapulmonary involvement in paediatric HIV disease. Pediatr Radiol. 2009;39(6):565-8.
24. Theron S, Andronikou S, George R, du Plessis J, Goussard P, Hayes M, et al. Non-infective pulmonary disease in HIV-positive children. Pediatr Radiol. 2009;39(6):555-64.
25. Nel ED, Ellis A. Swallowing abnormalities in HIV infected children: an important cause of morbidity. BMC Pediatr. 2012;12:68.
26. Desai SR, Copley SJ, Barker RD, Elston CM, Miller RF,Wells AU, et al. Chest radiography patterns in 75 adolescents with vertically-acquired human immunodeficiency virus (HIV) infection. Clin Radiol. 2011;66(3):257-63.
27. Dramowski A, Morsheimer MM, Frigati L, Schaaf HS, Rabie H, Sorour G, et al. Radiology services for children in HIV- and TB-endemic regions: scope for greater collaboration between radiologists and clinicians caring for children. Pediatr Radiol. 2009;39:541-44.
28. de Martino M, Veneruso G, Gabiano C, Frongia G, Tulisso S, Lombardi E, et al. Airway resistance and spirometry in children with perinatally acquired human immunodeficiency virus-type 1 infection. Pediatr Pulmonol. 1997; 24(6):406-14.
29. Miller RF, Kaski JP, Hakim J, Matenga J, Nathoo K, Munyati S, et al. Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis. 2013;56(4):576-82.
30. Epstein LJ, Strollo PJ, Donegan RB, Hendrix C, Westbrook RB. Obstructive sleep apnea in patients with human immunodeficiency virus (HIV) disease. Sleep. 1995;18(5):368-76.
31. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21):2233-44.
32. Cotton M, Violari A, Gibb D, Otwombe K, Josipovic D, Panchia R, et al. Early ART followed by Interruption Is Safe and Is Associated with Better Outcomes than Deferred ART in HIV+ Infants: Final Results from the 6- Year Randomized CHER Trial, South Africa. In: Programs and abstracts of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012); 2012 March 5-8; Seattle, Washington, USA.
33. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005;5(6):361-73.
34. Zampoli M, Kilborn T, Eley B. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children. Int J Tuberc Lung Dis. 2007;11(4):417-23.
35. George MP, Kannass M, Huang L, Sciurba FC, Morris A. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One. 2009;4(7):e6328.
36. Healy DP. Macrolide immunomodulation of chronic respiratory diseases. Curr Infect Dis Rep. 2007;9(1):7-13.
37. Hill AT, Pasteur M, Cornford C,Welham S, Bilton D. Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011;20(2):135-40.
38. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, et al. Cotrimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364(9448):1865-71.
39. Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, Nahirya-Ntege P, Keishanyu R, Kekitiinwa A, et al. Randomized comparison of stopping vs continuing cotrimoxazole prophylaxis among 758 HIV+ children on long-term ART: the anti-retroviral research for Watoto trial. In: Programs and abstracts of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013); 2013 March 3-6; Atlanta, Georgia, USA.
40. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011.